Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

120.80 -1.65 (-1.35%)
Streaming Delayed Price Updated: 2:19 PM EDT, Jun 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Moderna Inc

< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
99 100 Next >
Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2023
Via Benzinga
Did Nvidia Make Recursion Pharmaceuticals (RXRX) Stock the Next AI Play?
RXRX stock is the talk of Wall Street today after Recursion Pharmaceuticals shot up 100% on a new Nvidia investment. 
Via InvestorPlace
7 Biotech Stocks to Sell in July
Running the gamut from large to small, and from commercial stage to clinical stage, these are seven top biotech stocks to sell in July. 
Via InvestorPlace
Check Out What Whales Are Doing With MRNA
Via Benzinga
Is Moderna Heading for a Critical Moment?
Moderna predicts the coronavirus vaccine market will follow that of the flu shot. 
Via The Motley Fool
Moderna Unusual Options Activity
Via Benzinga
3 Things About Vertex Pharmaceuticals That Smart Investors Know
Vertex shares have advanced about 20% so far this year. 
Via The Motley Fool
EXCLUSIVE: The 20 Most-Searched For Tickers On Benzinga Pro From The First Six Months Of 2023
Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to get the latest breaking news on the overall market and individual tickers. 
Via Benzinga
What's Going On With Novavax (NVAX) Stock?
Novavax, Inc. (NASDAQ: NVAX) shares are trading higher on Monday after the company announced an amendment to its Canada supply agreement, under which the Government of Canada will pay Novavax $349.6... 
Via Benzinga
Tesla, Netflix And 2 Other Stocks Insiders Are Selling
The Nasdaq 100 closed lower on Friday following jobs data for June. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
Analyst Ratings for Moderna
Via Benzinga
Are We Heading for a Recession? Here's What Investors Should Do.
The stock market has rallied since the start of the year. 
Via The Motley Fool
Week In Review: Billion Dollar Deals - Moderna’s Shanghai Investment And F-Star’s Takeda Collaboration
F-star Therapeutics formed a license agreement with Takeda to develop Fcab domains aimed at undisclosed immuno-oncology targets. Also, Brii Bio signed a global license to an HBV immunotherapeutic... 
Via Talk Markets
A Big Test Is Looming for Pfizer, Moderna, and Novavax
Investors in these companies should brace for some potentially underwhelming results this year. 
Via The Motley Fool
3 Value Stocks to Consider Selling Before They Do Your Portfolio In
Looking to protect your portfolio? Learn the art of portfolio management by selling bad value stocks and identifying the right time to sell. 
Via InvestorPlace
What's Going On With Moderna Stock?
Moderna, Inc. (NASDAQ: MRNA) shares traded higher today after reports suggested the company signed a memorandum of understanding and land collaboration agreement to research, develop and manufacture... 
Via Benzinga
Moderna Strikes mRNA Drug Pact With Chinese Authorities: Report
Moderna Inc (NASDAQ: MRNA) reportedly struck a deal with Chinese authorities to research, develop, and manufacture messenger RNA (mRNA) medicines in the country. 
Via Benzinga
EXCLUSIVE: Top 10 Most-Searched Tickers On Benzinga Pro In Q2 — Tesla, Nvidia, C3.ai, Meta Platforms, Microsoft And More
Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to get the latest breaking news on the overall market and individual tickers. 
Via Benzinga
Moderna Initiates Regulatory Application Process Seeking Approval For Its RSV Vaccine In Older Adults
Moderna Inc (NASDAQ: MRNA) provided an update on regulatory submissions for the mRNA-1345 vaccine to prevent RSV-associated lower respiratory tract disease (RSV-LRTD) and acute respiratory disease in  
Via Benzinga
CarMax, Walmart And 2 Other Stocks Insiders Are Selling
The Nasdaq 100 closed higher by more than 200 points on Friday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
Moderna Seeks European Nod For Updated COVID-19 Vaccine Shot To Tackle New Dominant Strain
Moderna Inc (NASDAQ: MRNA) submitted a regulatory application to the European Medicines Agency (EMA) for its updated COVID-19 vaccine encoding the spike protein for the XBB.1.5  
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
3 Pharma Stocks That Have Big Investors Running for the Exit
Hedge funds, institutional investors and company insiders have been dumping shares of these risky pharma stocks. 
Via InvestorPlace
How to Invest $10,000 -- No Matter What the Market is Doing
You can apply these tips to investing $10,000 -- or any amount of money. 
Via The Motley Fool
Steve Weiss Once Predicted Moderna Stock Would Rise 500% And Trade Like Amazon: Now He's Selling As The CEO Dumps Shares
Short Hills Capital's Steve Weiss once predicted Moderna Inc (NASDAQ: MRNA) shares would make an Amazon-like move. 
Via Benzinga
Moderna Stock Price Forecast: UBS Sees A 60% Upside
Moderna stock is currently down about 40% versus its year-to-date high. 
Via Talk Markets
Post-COVID-19: How the COVAX Initiative Could Redirect its $2.6B Surplus to Fight Future Pandemics
As the emergency phase of the COVID-19 pandemic draws to a close, the COVAX initiative, run by Gavi, the WHO, and CEPI, reportedly has $2.6 billion left over that could be used to prepare for other... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 26, 2023
Via Benzinga
Moderna Pipeline For Any Vaccine Beyond Covid Is 'Underappreciated,' Analyst Says
Shares of Moderna Inc (NASDAQ: MRNA) rose in early trading on Monday, just days after the pharma company submitted an application to the Food and Drug Administration (FDA) for the 
Via Benzinga
< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.